J Cancer 2021; 12(5):1284-1294. doi:10.7150/jca.51346 This issue Cite

Review

The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma

Yu Huang1,2,3,4,5*, Wenhao Ge1,2,3,4,5*, Jiarong Zhou1,2,3,4,5, Bingqiang Gao1,2,3,4,5, Xiaohui Qian1,2,3,4,5, Weilin Wang1,2,3,4,5✉

1. Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
2. Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
3. Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, Zhejiang 310009.
4. Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang 310009.
5. Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
* These authors contributed equally to this work.

Citation:
Huang Y, Ge W, Zhou J, Gao B, Qian X, Wang W. The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma. J Cancer 2021; 12(5):1284-1294. doi:10.7150/jca.51346. https://www.jcancer.org/v12p1284.htm
Other styles

File import instruction

Abstract

Graphic abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and represents a classic paradigm of inflammation-related cancer. Various inflammation-related risk factors jointly contribute to the development of chronic inflammation in the liver. Chronic inflammation, in turn, leads to continuous cycles of destruction-regeneration in the liver, contributing to HCC development and progression. Tumor associated macrophages are abundant in the tumor microenvironment of HCC, promoting chronic inflammation and HCC progression. Hence, better understanding of the mechanism by which tumor associated macrophages contribute to the pathogenesis of HCC would allow for the development of novel macrophage-targeting immunotherapies. This review summarizes the current knowledge regarding the mechanisms by which macrophages promote HCC development and progression, as well as information from ongoing therapies and clinical trials assessing the efficacy of macrophage-modulating therapies in HCC patients.

Keywords: Hepatocellular carcinoma, Tumor associated macrophage, Tumor microenvironment, Immunotherapy


Citation styles

APA
Huang, Y., Ge, W., Zhou, J., Gao, B., Qian, X., Wang, W. (2021). The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma. Journal of Cancer, 12(5), 1284-1294. https://doi.org/10.7150/jca.51346.

ACS
Huang, Y.; Ge, W.; Zhou, J.; Gao, B.; Qian, X.; Wang, W. The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma. J. Cancer 2021, 12 (5), 1284-1294. DOI: 10.7150/jca.51346.

NLM
Huang Y, Ge W, Zhou J, Gao B, Qian X, Wang W. The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma. J Cancer 2021; 12(5):1284-1294. doi:10.7150/jca.51346. https://www.jcancer.org/v12p1284.htm

CSE
Huang Y, Ge W, Zhou J, Gao B, Qian X, Wang W. 2021. The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma. J Cancer. 12(5):1284-1294.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image